Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

August 18, 2022 01:02:07
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update
MitoAction Expert Series
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

Aug 18 2022 | 01:02:07

/

Show Notes

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Other Episodes

Episode 0

August 25, 2021 00:59:38
Episode Cover

Introducing the Ultragenyx LC-FAOD Disease Monitoring Programs: Our Commitment to Advancing LC-FAOD Research Globally

Join MitoAction, Laura Pisani-Betancourt and Kristin Voorhees from Ultragenyx Pharmaceutical on Friday, July 9th, 2021 at 12:00pm EST for our monthly expert series presentation!...

Listen

Episode 0

June 05, 2020 01:21:48
Episode Cover

Cool Ideas for Adults and Kids with Heat Intolerance - Maggie Orr - 5/2/08

MitoAction asked Maggie Orr, RN MSN EdM, Medical Advisory Board Member to join us to collaborate about heat intolerance and its causes.  We will...

Listen

Episode

May 19, 2022 01:14:29
Episode Cover

PDCD (Pyruvate Dehydrogenase Complex Deficiency)

What is the mitochondrial disorder PDCD? PDCD is an abbreviation for pyruvate dehydrogenase complex deficiency, a genetic mitochondrial disorder in children which is frequently...

Listen